Chemical activators of MRP-L14 can influence mitochondrial biogenesis and function by engaging various cellular pathways that converge on the mitochondria, the powerhouses of the cell. Resveratrol, for instance, activates SIRT1, a protein that supports mitochondrial function and biogenesis. This activation leads to an upsurge in mitochondrial protein synthesis, where MRP-L14 plays a crucial role as part of the mitochondrial ribosome complex. Similarly, metformin's activation of AMP-activated protein kinase (AMPK) stimulates mitochondrial biogenesis through the PGC-1α pathway, which in turn increases the demand for MRP-L14's participation in the construction of mitochondrial proteins. Pioglitazone, a PPAR-γ agonist, also enhances the activity of MRP-L14 by upregulating genes associated with mitochondrial function and biogenesis via the PGC-1α coactivator.
Leucine's role extends to the activation of the mTOR pathway, a key regulator of ribosomal function and assembly, thereby promoting MRP-L14's activity in mitochondrial protein translation. AICAR, another AMPK activator, mirrors the effects of metformin, resulting in heightened mitochondrial biogenesis and an increased functional demand for MRP-L14. Retinoic acid impacts gene expression to support mitochondrial function, necessitating active participation of MRP-L14 in new mitochondria. Spermidine facilitates autophagy and mitochondrial turnover, leading to renewal of mitochondria that require MRP-L14's role in protein synthesis. Bezafibrate, through its action as a PPAR agonist, elevates mitochondrial biogenesis and, correspondingly, the need for MRP-L14 activity. Urolithin A, by inducing mitophagy and supporting mitochondrial function, also implicates a need for the heightened activity of MRP-L14. Lastly, NMN, by serving as a precursor to NAD+ and activating SIRT1, indirectly supports the role of MRP-L14 by enhancing mitochondrial biogenesis and function. Alpha-lipoic acid, known for its involvement in mitochondrial bioenergetics, similarly implies an increased role for MRP-L14 in response to enhanced mitochondrial function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol can activate SIRT1, which is known to be involved in mitochondrial biogenesis and function. Given that MRP-L14 is a mitochondrial ribosomal protein, the activation of SIRT1 by Resveratrol could lead to enhanced mitochondrial protein synthesis, thus functionally activating MRP-L14 as part of the mitochondrial ribosome complex. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates AMP-activated protein kinase (AMPK), a sensor of cellular energy status. AMPK activation can lead to the enhancement of mitochondrial biogenesis through the PGC-1α pathway. As MRP-L14 is part of the mitochondrial ribosome, the increase in mitochondrial biogenesis would necessitate increased activity of MRP-L14 for protein synthesis within the organelle. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, a PPAR-γ agonist, can lead to the transcriptional activation of genes involved in mitochondrial function and biogenesis, through coactivator PGC-1α. This would logically enhance the activity of mitochondrial ribosomal proteins such as MRP-L14 by increasing the demand for mitochondrial protein synthesis. | ||||||
L-Leucine | 61-90-5 | sc-364173 sc-364173A | 25 g 100 g | $21.00 $62.00 | ||
Leucine is known to activate the mammalian target of rapamycin (mTOR) pathway, which is a critical regulator of protein synthesis. Through the activation of mTOR, leucine can enhance the assembly and function of ribosomes, including mitochondrial ribosomes, thereby functionally activating MRP-L14 by promoting its role in mitochondrial protein translation. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK, which can promote mitochondrial biogenesis and function indirectly through the PGC-1α pathway. As mitochondrial biogenesis increases, the functional demand for mitochondrial ribosomal proteins like MRP-L14 is elevated, leading to its activation as part of the mitochondrial ribosome. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can influence mitochondrial biogenesis and function by modulating gene expression profiles. Since MRP-L14 is integral to mitochondrial protein synthesis, an increase in mitochondrial biogenesis would necessitate an increase in MRP-L14 activity to meet the needs of the new mitochondria. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $57.00 $607.00 $176.00 | ||
Spermidine has been shown to induce autophagy and can lead to increased mitochondrial biogenesis and turnover. Autophagy induction often leads to renewal of cellular organelles, including mitochondria, which would require the activation of mitochondrial ribosomal proteins such as MRP-L14 to meet the protein synthesis demands of new mitochondria. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
Bezafibrate, through its role as a PPAR agonist, can increase mitochondrial biogenesis and fatty acid oxidation. The drug's effect on mitochondrial biogenesis may lead to an increased functional requirement for MRP-L14 in mitochondrial ribosomes to support enhanced mitochondrial protein synthesis. | ||||||
Urolithin A | 1143-70-0 | sc-475514 sc-475514A sc-475514B sc-475514C | 25 mg 100 mg 1 g 5 g | $204.00 $459.00 $714.00 $1224.00 | 10 | |
Urolithin A induces mitophagy and has been linked to the promotion of mitochondrial function. By enhancing the turnover and biogenesis of mitochondria, Urolithin A would increase the demand for mitochondrial ribosomal proteins, including MRP-L14, thereby functionally activating it. | ||||||
β-Nicotinamide mononucleotide | 1094-61-7 | sc-212376 sc-212376A sc-212376B sc-212376C sc-212376D | 25 mg 100 mg 1 g 2 g 5 g | $110.00 $150.00 $220.00 $300.00 $600.00 | 4 | |
NMN is a precursor to NAD+, which is a substrate for sirtuins, including SIRT1. Increased SIRT1 activity has been associated with enhanced mitochondrial function and biogenesis. As a mitochondrial ribosomal protein, MRP-L14 would be functionally activated to meet the increased demands of mitochondrial protein synthesis facilitated by NMN through SIRT1 activation. | ||||||